X0609 4 2026-04-27 true 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001443705 Harford Simon N.R. false 47 HULFISH STREET PRINCETON NJ 08542 false true false false Chief Financial Officer false Common Stock 2026-04-27 4 D false 143595 14.5 D 0 D Stock Options (right to buy) 12.62 2026-04-27 4 D false 189043 D 2033-08-21 Common Stock 189043 0 D Stock Options (right to buy) 14.24 2026-04-27 4 D false 99073 D 2034-01-02 Common Stock 99073 0 D Stock Options (right to buy) 9.41 2026-04-27 4 D false 150517 D 2035-01-03 Common Stock 150517 0 D The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 108,478 shares of Common Stock and 35,117 restricted stock units (which vested in full in connection with consummation of the Merger). In connection with consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment equal to (a) the excess of (i) $14.50 per share over (ii) the exercise price payable per share, multiplied by (b) the total number of shares subject to such Option. Each Option vested in full in connection with consummation of the Merger. /s/ Christian Formica, Attorney-in-Fact 2026-04-27